Articles dans des revues avec comité de lecture (191)
  1. 1. Helali, Y., Bourez, A., Marchant, A., Vander Heyden, Y., Van Antwerpen, P., & Delporte, C. (2024). Development and validation of online SPE purification coupled to HILIC-fluorescence-MS analysis for the characterization of N-glycans. Talanta, 270, 125541. doi:10.1016/j.talanta.2023.125541
  2. 2. Gemander, N., Kemlin, D., Depickère, S., Kelkar, N. N., Pannus, P., Sharma, S., Waegemans, A., Olislagers, V., Georges, D., Dhondt, E., Braga, M., Heyndrickx, L., Michiels, J., Thiriard, A., Lemy, A., Vandevenne, M., Goossens, M. M., Matagne, A., Desombere, I., Ariën, K., Ackerman, M. M., Le Moine, A., & Marchant, A. (2024). Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients. Kidney International Reports, 9(3), 635-648. doi:10.1016/j.ekir.2023.12.008
  3. 3. Sharma, S., Thiriard, A., Olislagers, V., Lechien, J. R., Jurion, M.-H., Delforge, M.-L., Marchant, A., & Saussez, S. (2024). Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction. Journal of medical virology, 96(1), e29398. doi:10.1002/jmv.29398
  4. 4. De Weerdt, L., Thiriard, A., Leuridan, E., Marchant, A., & Maertens, K. (2024). Immunogenicity at delivery after Tdap vaccination in successive pregnancies. Frontiers in immunology, 15, 1360201. doi:10.3389/fimmu.2024.1360201
  5. 5. Marchant, A., Van Damme, P., Plotkin, S., Neels, P., Cassetti, M. C., Cramer, J., Gruber, M. F., Goldblatt, D., King, D., Hartig-Merkel, W., & Vandeputte, J. (2023). Enabling the evaluation of COVID-19 vaccines with correlates of protection. Biologicals, 85, 101723. doi:10.1016/j.biologicals.2023.101723
  6. 6. Hederman, A. P., Natarajan, H., Heyndrickx, L., Ariën, K. K., Wiener, J. A., Wright, P. F., Bloch, E. M., Tobian, A. A. R., Redd, A. D., Blankson, J. N., Rottenstreich, A., Zarbiv, G., Wolf, D., Goetghebuer, T., Marchant, A., & Ackerman, M. M. (2023). SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations. Nature communications, 14(1), 5171. doi:10.1038/s41467-023-40960-0
  7. 7. Taton, M., Willems, F., Widomski, C., Martin, C., Jiang, Y., Renard, K., Cogan, A., Necsoi, C. V., Ackerman, M. M., Marchant, A., & Dauby, N. (2023). Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization. Vaccine. doi:10.1016/j.vaccine.2023.05.035
  8. 8. Pannus, P., Depickère, S., Kemlin, D., Georges, D., Houben, S., Olislagers, V., Waegemans, A., De Craeye, S., Francotte, A., Chaumont, F., Van Oostveldt, C., Heyndrickx, L., Michiels, J., Willems, E., Dhondt, E., Krauchuk, M., Schmickler, M.-N., Verbrugghe, M., Van Loon, N., Dierick, K., Matagne, A., Desombere, I., Ariën, K. K., Marchant, A., & Goossens, M. M. (2023). Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults. Vaccine, 41(17), 2829-2836. doi:10.1016/j.vaccine.2023.03.047
  9. 9. Erdem, R., De Coster, I., Withanage, K., Mercer, L. L., Marchant, A., Taton, M., Cools, N., Lion, E., Cassels, F., Higgins, D., Ivinson, K., Locke, E., Mahmood, K., Wright, P. F., Gast, C., White, J. A., Ackerman, M. M., Konopka-Anstadt, J. J., Mainou, B. B., & Van Damme, P. (2023). Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Vaccine, 41(10), 1657-1667. doi:10.1016/j.vaccine.2023.01.048
  10. 10. Kemlin, D., Gemander, N., Depickère, S., Olislagers, V., Georges, D., Waegemans, A., Pannus, P., Lemy, A., Goossens, M. M., Desombere, I., Michiels, J., Vandevenne, M., Heyndrickx, L., Ariën, K. K., Matagne, A., Ackerman, M. M., Le Moine, A., & Marchant, A. (2023). Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients. American Journal of Transplantation. doi:10.1016/j.ajt.2023.02.015
  11. 11. Thiriard, A., Meyer, B., Eberhardt, C. S., Loevy, N., Grazioli, S., Adouan, W., Fontannaz, P., Marechal, F., L'Huillier, A. G., Siegrist, C.-A., Georges, D., Putignano, A., Marchant, A., Didierlaurent, A. M., & Blanchard-Rohner, G. (2023). Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19. Frontiers in immunology, 14, 1107156. doi:10.3389/fimmu.2023.1107156
  12. 12. Ariën, K., Heyndrickx, L., Michiels, J., Vereecken, K., Van Lent, K., Coppens, S., Willems, B., Pannus, P., Martens, G. A., Van-Esbroeck, M., Goossens, M. M., Marchant, A., Bartholomeeusen, K., & Desombere, I. (2022). Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant. NPJ vaccines, 7(1), 35. doi:10.1038/s41541-022-00459-z
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>